Transcription of Guideline on development, production, characterisation and ...
{{id}} {{{paragraph}}}
Example: tourism industry
Guideline on development, production, characterisation and ...
30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged. 21 July 2016 EMA/CHMP/BWP/532517/2008 Committee for medicinal products for human use (CHMP) Guideline on development , production, characterisation and specification for monoclonal antibodies and related products 3R s technical update January 2016 Agreed by Biologics Working Party January 2016 Adopted by CHMP July 2016 Date for coming into effect September 2016 * This is a technical update to reflect current best practice with regard to implementation of 3Rs approaches and it is not intended as a full revision of this Guideline (only sections 1, and are affected).
When one or more specific procedures are performed during development, prior to the isolation of the monoclonal cell line, such as cell fusion, viral transformation, gene library of phage display screening, application of
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: